| Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis MS Sandrin, WL Fodor, E Mouthtouris, N Osman, S Cohney, SA Rollins, ... Nature Medicine 1 (12), 1261-1267, 1995 | 412 | 1995 |
| Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions A Sharif, M Hecking, APJ De Vries, E Porrini, M Hornum, ... American Journal of Transplantation 14 (9), 1992-2000, 2014 | 373 | 2014 |
| New-onset diabetes after kidney transplantation—changes and challenges CJ Yates, S Fourlanos, J Hjelmesaeth, PG Colman, SJ Cohney American Journal of Transplantation 12 (4), 820-828, 2012 | 201 | 2012 |
| Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression SM Flint, RG Walker, C Hogan, MN Haeusler, A Robertson, DMA Francis, ... American journal of transplantation 11 (5), 1016-1024, 2011 | 146 | 2011 |
| KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. SJ Chadban, KA Barraclough, SB Campbell, CJ Clark, PT Coates, ... Nephrology 17 (3), 2012 | 85 | 2012 |
| ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone R Masterson, P Hughes, RG Walker, C Hogan, M Haeusler, ... American journal of transplantation 14 (12), 2807-2813, 2014 | 79 | 2014 |
| DOWN-REGULATION OF Galα (1, 3) Gal EXPRESSION BY α1, 2-FUCOSYLTRANSFERASE: Further Characterization of α1, 2-Fucosyltransferase Transgenic Mice: 1 S Cohney, IFC McKenzie, K Patton, J Prenzoska, K Ostenreid, WL Fodor, ... Transplantation 64 (3), 495-500, 1997 | 70 | 1997 |
| Impact of statin treatment on 1-year functional and histologic renal allograft outcome R Masterson, T Hewitson, M Leikis, R Walker, S Cohney, G Becker Transplantation 80 (3), 332-338, 2005 | 52 | 2005 |
| Efficacy of Sotrastaurin Plus Tacrolimus After De Novo Kidney Transplantation: Randomized, Phase II Trial Results GR Russ, H Tedesco‐Silva, DR Kuypers, S Cohney, RM Langer, O Witzke, ... American Journal of Transplantation 13 (7), 1746-1756, 2013 | 50 | 2013 |
| Reduction of the major porcine xenoantigen Galoc (1, 3) Gal by expression of α (1, 2) fucosyltransferase MS Sandrin, WL Fodor, S Cohney, E Mouhtouris, N Osman, SA Rollins, ... Xenotransplantation 3 (1), 134-140, 1996 | 37 | 1996 |
| New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study I Ruderman, R Masterson, C Yates, A Gorelik, SJ Cohney, RG Walker Nephrology 17 (1), 89-96, 2012 | 35 | 2012 |
| Molecular Cloning of the Gene Coding for pig α1→ 2fucosyltransferase S Cohney, E Mouhtouris, IFC McKenzie, MS Sandrin Immunogenetics 44, 76-79, 1996 | 35 | 1996 |
| Lessons and insights from ABO-incompatible lung transplantation GI Snell, M Holmes, BJ Levvey, A Shipp, C Robertson, GP Westall, ... American Journal of Transplantation 13 (5), 1350-1353, 2013 | 24 | 2013 |
| Strategies to overcome the anti-Gal alpha (1-3) Gal reaction in xenotransplantation IF McKenzie, N Osman, S Cohney, HA Vaughan, K Patton, E Mouhtouris, ... Transplantation proceedings 28 (2), 537, 1996 | 22 | 1996 |
| Lupus anticoagulant in anti-neutrophil cytoplasmic antibody-associated polyarteritis S Cohney, J Savige, MR Stewart American journal of nephrology 15 (2), 157-160, 1995 | 20 | 1995 |
| Overcoming the anti-galα (1–3) gal reaction to avoid hyperacute rejection: Molecular genetic approaches MS Sandrin, S Cohney, N Osman, IFC McKenzie Xenotransplantation: The transplantation of organs and tissues between …, 1997 | 17 | 1997 |
| Kidney Health australia Caring for australians with renal Impairment (KHa-CarI). KHa-CarI guideline: KHa-CarI adaptation of the KDIgo Clinical Practice guideline for the Care … SJ Chadban, KA Barraclough, SB Campbell, CJ Clark, PT Coates, ... Nephrology (Carlton) 17, 204-214, 2012 | 15 | 2012 |
| Molecular cloning and characterization of the pig secretor type alpha 1, 2fucosyltransferase (FUT2). S Cohney, E Mouhtouris, IF McKenzie, MS Sandrin International Journal of Molecular Medicine 3 (2), 199-406, 1999 | 12 | 1999 |
| Blood group incompatibility in kidney transplantation: definitely time to re-examine! SJ Cohney, RG Walker, MN Haeusler, DM Francis, CJ Hogan The Medical Journal of Australia 187 (5), 306-308, 2007 | 11 | 2007 |
| C5 Inhibition with Eculizumab To Prevent Antibody Mediated Rejection (AbMR) in Patients with Donor Specific Anti-HLA Antibody (DSAb) and a Positive Cross Match. SJ Cohney, P Hughes, M Rosemary, RG Walker, L Cantwell, ... AMERICAN JOURNAL OF TRANSPLANTATION 11, 483-483, 2011 | 10 | 2011 |
